DR. HARRY B BURKE, MD
Osteopathic Medicine at Wisconsin Ave, Bethesda, MD
License number
Maryland MD33439
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
8901 Wisconsin Ave, Bethesda, MD 20889
12432 Grace Hill Ln, Glen Allen, VA 23059
12432 Grace Hill Ln, Glen Allen, VA 23059
Phone
(301) 938-2212
Personal information
See more information about HARRY B BURKE at radaris.comName
Address
Phone
PO Box 16254, Alexandria, VA 22302
9404 Balfour Dr, Bethesda, MD 20814
931 Ashland Ave, Bedford, VA 24523
911 W 49Th St, Richmond, VA 23225
12301 Pretoria Dr, Silver Spring, MD 20904
Professional information
Dr. Harry B Burke, Washington DC - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
2300 I St NW SUITE 558, Washington 20052
(301) 938-2212 (Phone), (202) 741-2185 (Fax)
8901 Wisconsin Ave, Bethesda 20889
(301) 938-2212 (Phone)
(301) 938-2212 (Phone), (202) 741-2185 (Fax)
8901 Wisconsin Ave, Bethesda 20889
(301) 938-2212 (Phone)
Languages:
English
Hospitals:
2300 I St NW SUITE 558, Washington 20052
8901 Wisconsin Ave, Bethesda 20889
The George Washington University Hospital
900 23Rd St North #West, Washington 20037
8901 Wisconsin Ave, Bethesda 20889
The George Washington University Hospital
900 23Rd St North #West, Washington 20037
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1988
St Francis Hospital Of Evanston
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1988
St Francis Hospital Of Evanston
Harry B Burke, Bethesda MD
Specialties:
Internist
Address:
4301 Jones Bridge Road, Bethesda, MD 20814
Catheter For Enhanced Image Location Detection
US Patent:
2009005, Feb 26, 2009
Filed:
Aug 24, 2007
Appl. No.:
11/844684
Inventors:
Harry B. Burke - Glen Allen VA, US
International Classification:
A61M 25/095
US Classification:
600424
Abstract:
A catheter is used to assist in imaging, e.g., 3D imaging, an anatomical location in a human or veterinary subject. The catheter includes a plurality of horizontal markings which extend in the longitudinal direction between the distal and proximal ends. The horizontal markings can be made throughout the entire length of the catheter, or at one or more locations. At each location, the horizontal markings will appear as successive sets of markings. Each horizontal marking is made of two markings that are the same length. The two markings are arranged such that identically sized gaps between the ends of the markings are positioned on the front and back side of the catheter. In one embodiment, an image where the source and catheter are precisely aligned will show gaps of succeeding larger or smaller sizes. However, when the source is off center the gap lengths will be smaller or not exist. Particular marking locations can be highlighted by using relatively thinner or thicker markings and/or by spacing the markings progressively closer together or further apart.
Prediction Of Bare Metal Stent Restenosis
US Patent:
7550300, Jun 23, 2009
Filed:
Nov 29, 2007
Appl. No.:
11/947119
Inventors:
Conor F. Lundergan - Ellicott City MD, US
Harry B. Burke - Glen Allen VA, US
Timothy A. McCaffrey - Silver Spring MD, US
Harry B. Burke - Glen Allen VA, US
Timothy A. McCaffrey - Silver Spring MD, US
Assignee:
CapGen Sciences, Inc. - Elliocott City MD
International Classification:
G01N 33/00, C12Q 1/68, C12M 1/34, C07H 21/04
US Classification:
436 94, 435 6, 4352872, 536 231, 536 235, 536 2431
Abstract:
Methods for predicting whether or not a patient is likely to experience restenosis after the placement of a bare metal stent are provided. The methods involve detecting and analyzing gene expression patterns of the cellular components of whole blood, where activation of selected genes has been found to be indicative of a high probability of restenosis. The method thus allows the identification, prior to placement of a stent, of patients who are i) likely to experience restenosis, and thus should receive a stent that includes anti-restenosis agents; or ii) unlikely to experience restenosis, and thus should receive a stent without anti-stenosis agents.